NASDAQ:SILO Silo Pharma (SILO) Stock Price, News & Analysis $2.32 +0.21 (+9.95%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$2.01▼$2.3850-Day Range$0.86▼$3.4752-Week Range$0.84▼$4.50Volume1.94 million shsAverage Volume2.34 million shsMarket Capitalization$8.63 millionP/E RatioN/ADividend YieldN/APrice Target$10.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get Silo Pharma alerts: Email Address Silo Pharma MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside331.0% Upside$10.00 Price TargetShort InterestHealthy2.52% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.19Based on 7 Articles This WeekInsider TradingAcquiring Shares$607 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.96 out of 5 stars 3.5 Analyst's Opinion Consensus RatingSilo Pharma has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageSilo Pharma has received no research coverage in the past 90 days.Read more about Silo Pharma's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.52% of the float of Silo Pharma has been sold short.Short Interest Ratio / Days to CoverSilo Pharma has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Silo Pharma has recently increased by 30.56%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSilo Pharma does not currently pay a dividend.Dividend GrowthSilo Pharma does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SILO. Previous Next 2.3 News and Social Media Coverage News SentimentSilo Pharma has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Silo Pharma this week, compared to 1 article on an average week.Search Interest24 people have searched for SILO on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Silo Pharma to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silo Pharma insiders have bought more of their company's stock than they have sold. Specifically, they have bought $607.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 5.56% of the stock of Silo Pharma is held by insiders.Percentage Held by InstitutionsOnly 5.58% of the stock of Silo Pharma is held by institutions.Read more about Silo Pharma's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Book Value per Share RatioSilo Pharma has a P/B Ratio of 1.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Silo Pharma's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad American Hartford Gold GroupDave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About Silo Pharma Stock (NASDAQ:SILO)Silo Pharma. Inc., a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief. The company's preclinical products include SPC-14 to treat Alzheimer's disease; and SPU-16, a central nervous system homing peptide targeting the central nervous system with indication in multiple sclerosis. It also seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin and ketamine, as well as depression, mental health issues, and neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.Read More SILO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SILO Stock News HeadlinesJuly 26 at 8:20 AM | globenewswire.comSilo Pharma to Present at H.C. Wainwright Annual Global Investment ConferenceJuly 22, 2024 | globenewswire.comSilo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 19, 2024 | finanznachrichten.deSilo Pharma, Inc.: Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJuly 19, 2024 | msn.com3 Penny Stocks to Watch Now, 7/18/24July 19, 2024 | msn.comSilo Pharma Finds Partner For Device Development for Intranasal PTSD DrugJuly 19, 2024 | globenewswire.comSilo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJuly 18, 2024 | investorplace.comWhy Is Silo Pharma (SILO) Stock Up 60% Today?July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 18, 2024 | globenewswire.comSilo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15July 16, 2024 | benzinga.comWhy Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?July 16, 2024 | investorplace.comWhy Is Silo Pharma (SILO) Stock Up 123% Today?July 16, 2024 | globenewswire.comSilo Pharma Secures Exclusive Global License for Alzheimer's TherapeuticJune 26, 2024 | globenewswire.comSilo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and AnxietyJune 7, 2024 | globenewswire.comSilo Pharma Announces Successful Production of its SP-26 Ketamine Implant for FibromyalgiaJune 6, 2024 | globenewswire.comSilo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJune 4, 2024 | globenewswire.comSilo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and AnxietyMay 23, 2024 | msn.comJaguar Health, Altamira Therapeutics,Erasca among healthcare moversSee More Headlines Receive SILO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silo Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today7/26/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Apparel, finished products from fabrics & similar materials Sub-IndustryApparel Current SymbolNASDAQ:SILO CUSIPN/A CIK1514183 Websilopharma.com Phone(718) 400-9031FaxN/AEmployees2Year FoundedN/APrice Target and Rating Average Stock Price Target$10.00 High Stock Price Target$10.00 Low Stock Price Target$10.00 Potential Upside/Downside+331.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,700,000.00 Net Margins-4,992.30% Pretax Margin-4,895.14% Return on Equity-51.75% Return on Assets-41.59% Debt Debt-to-Equity RatioN/A Current Ratio7.87 Quick Ratio7.87 Sales & Book Value Annual Sales$70,000.00 Price / Sales123.29 Cash FlowN/A Price / Cash FlowN/A Book Value$2.14 per share Price / Book1.08Miscellaneous Outstanding Shares3,720,000Free Float2,647,000Market Cap$8.63 million OptionableNot Optionable Beta0.08 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Eric Weisblum (Age 54)Chairman, President & CEO Comp: $569.01kMr. Daniel E. Ryweck (Age 59)Chief Financial Officer Comp: $62.69kDr. James S. Kuo M.B.A. (Age 59)M.D., Vice President of Research & Development Key CompetitorsThe Baldwin Insurance GroupNASDAQ:BRPErmenegildo ZegnaNYSE:ZGNUnder ArmourNYSE:UAAUnder ArmourNYSE:UASuperior Group of CompaniesNASDAQ:SGCView All CompetitorsInsidersEric WeisblumBought 562 shares on 6/11/2024Total: $606.96 ($1.08/share)Eric WeisblumBought 600 shares on 4/4/2024Total: $1,176.00 ($1.96/share)Eric WeisblumBought 1,100 shares on 4/1/2024Total: $2,101.00 ($1.91/share)Eric WeisblumBought 3,408 shares on 3/28/2024Total: $6,611.52 ($1.94/share)Eric WeisblumBought 500 shares on 12/19/2023Total: $815.00 ($1.63/share)View All Insider Transactions SILO Stock Analysis - Frequently Asked Questions How have SILO shares performed this year? Silo Pharma's stock was trading at $1.44 at the beginning of the year. Since then, SILO stock has increased by 61.1% and is now trading at $2.32. View the best growth stocks for 2024 here. How were Silo Pharma's earnings last quarter? Silo Pharma, Inc. (NASDAQ:SILO) announced its earnings results on Monday, May, 13th. The company reported ($0.28) earnings per share for the quarter. The firm had revenue of $0.02 million for the quarter. Silo Pharma had a negative net margin of 4,992.30% and a negative trailing twelve-month return on equity of 51.75%. How do I buy shares of Silo Pharma? Shares of SILO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SILO) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
